ESC Premium Access

Triple therapy: still an option?

Presentation

About the speaker

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
40 presentations
6 followers

3 more presentations in this session

A historical perspective: why we opted triple therapy for so long and what made us change our mind.

Speaker: Doctor D. Angiolillo (Jacksonville, US)

Thumbnail

Dual versus triple antithrombotic therapy, does trial design make the difference?

Speaker: Professor R. Storey (Sheffield, GB)

Thumbnail

Dual versus triple antithrombotic therapy - The fine art of personalised medicine.

Speaker: Professor R. De Caterina (Pisa, IT)

Thumbnail

Access the full session

Dual versus Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Stenting

Speakers: Professor K. Huber, Doctor D. Angiolillo, Professor R. Storey, Professor R. De Caterina
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

This platform is supported by

logo Novo Nordisk